Shares are at $2.55 and climbing on 13,000 plus trades and volume of only 2.3 million previous highs earlier this year saw the stock hit $6.0 on more than 27 million shares of volume.
XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial